NeuroVive: NeuroVive Strengthens Its Organization With The Recruitment Of Cecilia Hofvander As IR And Communications Director

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

NeuroVive Pharmaceutical AB (publ) (STO:NVP), the mitochondrial medicine company, announces that it has recruited Cecilia Hofvander as Investor Relations and Communications Director effective from 1 June 2016 in order to strengthen the company’s communication resources.

MORE ON THIS TOPIC